Roger J. Bedimo, MD, MS

Roger J. Bedimo, MD, MS

University of Texas Southwestern Medical Cente

Director, Infectious Disease Fellowship Training
University of Texas Southwestern Medical Center
Dallas, Texas

Committees and Organizations

  • Member, HIV Malignancy Working Group, NIAID, NIH
  • Member, The Infectious Disease Society of America
  • Member, The American Medical Association
  • Member, The American College of Physicians
  • Member, The American Society of Tropical Medicine and Hygiene
  • Member, The Royal Society of Tropical Medicine and Hygiene

Honors and Awards

  • Recognition for excellence in abstract submission, IDSA 2003 Travel Grant (2003)
  • NIH-sposnored Clinical Investigator Fellowship Award, The University of Alabama at Birmingham (2002)
  • Resident of the Year, Miami Valley Hospital (2001)
  • Teacher of the Year, Wright State University School of Medicine (2001)


  • University of Yaounde, Cameroon, MD (1989)
  • Tulane University, MS, Parasitology (1997)
  • Wright State University Medical School, Internal Medicine Residency (2001)
  • University of Alabama at Birmingham, Infectious Disease Fellowship (2003)

Selected Publications

  1. Busti AJ, Bedimo R, Margolis D, Hardin D. Improvement in Insulin Sensitivity and Dyslipidemia in Protease Inhibitor-Treated Patients After Switch to Atazanavir/Ritonavir (ATV/RTV): A Prospective Study Using Hyperinsulinemic, Euglycemic Clamp Testing. Antivir Ther. 2006;11:L37.
  2. Kaur R, Bedimo R, Kvanli M, Turner D, Shaw L, and Margolis D. A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil. AIDS Research and Therapy. 2006;26;3:16.
  3. Bedimo R, Ghurani R, Nsuami M, Turner D, Kvanli M, Brown G, and Margolis D. Lipid Abnormalities In HIV/HCV Co-Infected Patients. HIV Med. In press.
  4. Bridges D, Bedimo R. Severe Tuberculosis Sepsis in an Immunocompetent Patient. Am J Med. 2006;119:e11-14.
  5. Bedimo R, Chen R, Westfall A, Raper J, Allison J and Saag, M. Sustained HIV Viral Suppression Following Treatment Interruption: An Observational Study. AIDS Res Hum Retroviruses. 2006;22:40-44.
  6. Bedimo R, Hoesley C, Saag M. Non-AIDS-Defining Malignancies in the HAART era. Reply to Dal Maso et al. Clin Infect Dis. 2005;41:126-127.
  7. Marinella MA, Burdette SD, Bedimo R, Markert RJ. Leukemoid reactions complicating colitis due to Clostridium difficile. South Med J. 2004;97:959-963.
  8. Bedimo R, Chen R, Accort N, et al. Trends in AIDS-Defining and Non-AIDS-Defining Malignancies Among HIV-Infected Patients: 1989 to 2002. Clin Infect Dis. 2004;39:1380-1384.
  9. Bahebeck J, Bedimo R, Eyenga V, Kouamfack C, Kingue T, Nierenet M, Sosso M.. The management of musculoskeletal infection in HIV carriers. Acta Orthop Belg. 2004;70:355-360.
  10. Bedimo R, Geisler W. Dilantin Hypersensitivity Syndrome Masquerading as Fever and Systemic Illness of Unknown Origin in an HIV-Infected Patient. Int J STD AIDS. 2005;16:178-179.